Follow the 그린생명과학 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 그린생명과학 has logged 31 insider filings. Market capitalisation: €42.4bn. The latest transaction was disclosed on 22 June 2026 (Other). Among the most active insiders: 건덕상사. The full history is openly available.
30
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,864 of 29,063 companies
19.1
score / 100
Value
23
Quality
16
FCF yld-1.8%
Earn yld0.2%
EV/EBITDA45.8x
ROE·
Gross mgn6.1%
Net mgn0.3%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Green Life Science is a company in the health and pharmaceutical sector listed on the XKRX market. It focuses on developing innovative solutions in the life sciences field.